Post-COVID-19 syndrome management: Utilizing the potential of dietary polysaccharides

Biomed Pharmacother. 2023 Oct:166:115320. doi: 10.1016/j.biopha.2023.115320. Epub 2023 Aug 17.

Abstract

The COVID-19 pandemic has caused significant global impact, resulting in long-term health effects for many individuals. As more patients recover, there is a growing need to identify effective management strategies for ongoing health concerns, such as post-COVID-19 syndrome, characterized by persistent symptoms or complications beyond several weeks or months from the onset of symptoms. In this review, we explore the potential of dietary polysaccharides as a promising approach to managing post-COVID-19 syndrome. We summarize the immunomodulatory, antioxidant, antiviral, and prebiotic activities of dietary polysaccharides for the management of post-COVID-19 syndrome. Furthermore, the review investigates the role of polysaccharides in enhancing immune response, regulating immune function, improving oxidative stress, inhibiting virus binding to ACE2, balancing gut microbiota, and increasing functional metabolites. These properties of dietary polysaccharides may help alleviate COVID-19 symptoms, providing a promising avenue for effective treatment strategies.

Keywords: Antiviral; Gut microbiota; Immunomodulation; Oxidative stress; Polysaccharides; Post-COVID-19.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • COVID-19*
  • Dietary Carbohydrates
  • Humans
  • Pandemics
  • Polysaccharides / therapeutic use
  • Post-Acute COVID-19 Syndrome

Substances

  • Polysaccharides
  • Antioxidants
  • Dietary Carbohydrates